Lantern Pharma Inc. Corporate Analyst Meeting Transcript
Good afternoon, everyone. I'm Nicole Leber with Investor Relations at Lantern Pharma, and welcome to Lantern's Childhood Cancer Awareness Month Key Opinion Leader Webinar. September is Childhood Cancer Awareness Month, a month dedicated to supporting, empowering and amplifying the voice of the childhood cancer community. According to the American Childhood Cancer Organization, childhood cancer is the #1 cause of death by disease for children in the United States with 1 out of 6 diagnosed children not surviving past 5 years of age. Additionally, despite advances in medicine, many childhood cancers remain incurable. As of 2020, only 6 new drugs have been developed to treat childhood cancers.
For today's KOL webinar, you'll be listening to Dr. Peter Houghton, who has dedicated his career to improving our understanding of pediatric cancers and to the development of therapies that will improve survival outcomes for childhood cancer patients. He is currently a professor and principal investigator at the Greehey
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |